In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: CME Group's current price at $315.87 sits below the PERT-weighted fair value of $359.14, indicating a potential valuation upside of 13.7%. High leverage and low growth scores highlight risk factors, while Monte Carlo results show wide valuation dispersion with significant volatility (105% CV) and 50% downside risk below current price. Robust profitability contrasts with moderate efficiency, reflecting mixed fundamentals amid valuation uncertainty.